Drug Profile
Trimethoprim - Allegis Pharmaceuticals
Alternative Names: PrimsolLatest Information Update: 06 Oct 2021
Price :
$50
*
At a glance
- Originator Ascent Pediatrics Inc.
- Developer Allegis Pharmaceuticals
- Class Antibacterials; Diaminopyrimidines
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Otitis media; Urinary tract infections